Immunity and immunosuppression in experimental visceral leishmaniasis.
about
Regulatory T cells suppress T cell activation at the pathologic site of human visceral leishmaniasisExperimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins.Mechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB/c mouse versus Syrian hamster model.Intranasal vaccination with leishmanial antigens protects golden hamsters (Mesocricetus auratus) against Leishmania (Viannia) Braziliensis infectionProtein malnutrition impairs the immune response and influences the severity of infection in a hamster model of chronic visceral leishmaniasis.Recent advances in vaccines for leishmaniasis.Glycyrrhizic acid-mediated subdual of myeloid-derived suppressor cells induces antileishmanial immune responses in a susceptible host.A new model of progressive visceral leishmaniasis in hamsters by natural transmission via bites of vector sand fliesClinical, hematological and biochemical alterations in hamster (Mesocricetus auratus) experimentally infected with Leishmania infantum through different routes of inoculation.FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine.Immunoactivation and immunopathogeny during active visceral leishmaniasis.Immunity to visceral leishmaniasis: implications for immunotherapy.Dynamics of immunosuppression in hamsters with experimental visceral leishmaniasis.The Cytotoxic T Lymphocyte Antigen-4 +49A/G Single Nucleotide Polymorphism Association With Visceral Leishmaniasis.Leishmania (Leishmania) chagasi-infected mice as a model for the study of glomerular lesions in visceral leishmaniasis.Leishmania major abrogates gamma interferon-induced gene expression in human macrophages from a global perspective.Osteomyelitis and discospondylitis due to Scedosporium apiospermum in a dog.Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.Unresponsiveness of Mycobacterium w vaccine in managing acute and chronic Leishmania donovani infections in mouse and hamster.A Leishmania infantum cytosolic tryparedoxin activates B cells to secrete interleukin-10 and specific immunoglobulin.High prevalence of asymptomatic Leishmania spp. infection among liver transplant recipients and donors from an endemic area of Brazil.Severe visceral leishmaniasis in children: the relationship between cytokine patterns and clinical features.Immune response pattern of the popliteal lymph nodes of dogs with visceral leishmaniasis
P2860
Q28480551-ECE74FD5-D5C8-47D1-8403-3C082528D9ECQ33732102-F6E3B191-84F8-476D-BCBB-647DB77D4302Q34639315-26D53B97-3F4D-4DAA-9925-BE4EC84D9AF5Q34875401-7CB9999F-44BF-49EF-9472-5C1F849E8B3EQ35107259-619A8AAC-0EE4-4580-8AE9-A6AE10EEA885Q35873792-CA00E1AE-0F5B-4BA6-82F3-7CF5793FAE15Q36281325-0B778510-49F9-4B0D-AD22-A10503778863Q36702606-8B9380BC-166D-45AB-BE83-5F522261538CQ36749036-EF5045C0-3941-41D0-B6F2-7FC73D92BC11Q37229935-C33D5344-8EF2-47F3-9C8E-4BBA6E49F827Q37628522-195D405A-1C45-4DE8-B4E3-235524F96ECBQ38243220-14C92BD2-6430-4917-9DBC-93FC96E82446Q39001140-76C347F4-E53C-44C7-9FB1-93A60CD84763Q39041628-9B71E07E-475D-44C8-8641-566E0062FF3DQ39368564-9604BD89-7639-4A45-AE13-D0CE82515FE7Q40139059-A4149858-2F34-4CA6-917C-BC586E36CB06Q40399791-BFD153DB-8126-4A91-86A9-88C74ED42BA6Q42118281-AE57FD3D-1C8A-4D4A-A925-CC5AE4D8D33CQ44606808-152FFD37-9D49-4CD3-9FC1-E36C420F67BEQ46889693-AB7620A8-1A0E-46E0-8163-ACBA8FDEF120Q54230465-62953537-DD96-4559-BA9B-5C4DBD7383C4Q54325024-DC26AC70-0F4C-4C7D-806E-988DCA9CCC63Q58863132-757F988E-12D2-4B76-9BE3-A8CD642AAFBF
P2860
Immunity and immunosuppression in experimental visceral leishmaniasis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Immunity and immunosuppression in experimental visceral leishmaniasis.
@ast
Immunity and immunosuppression in experimental visceral leishmaniasis.
@en
type
label
Immunity and immunosuppression in experimental visceral leishmaniasis.
@ast
Immunity and immunosuppression in experimental visceral leishmaniasis.
@en
prefLabel
Immunity and immunosuppression in experimental visceral leishmaniasis.
@ast
Immunity and immunosuppression in experimental visceral leishmaniasis.
@en
P2860
P1476
Immunity and immunosuppression in experimental visceral leishmaniasis
@en
P2093
J A L Lindoso
P2860
P304
P356
10.1590/S0100-879X2004000400020
P407
P50
P577
2004-03-23T00:00:00Z